GI
NVAX icon

GAMMA Investing’s Novavax NVAX Stock Holding History

GAMMA Investing’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.97K Sell
952
-160
-14% -$1.43K ﹤0.01% 3266
2026
Q1 		$9.05K Buy
1,112
+503
+83% +$4.56K ﹤0.01% 3118
2025
Q4 		$4.09K Sell
609
-1,050
-63% -$7.92K ﹤0.01% 3365
2025
Q3 		$14.4K Buy
1,659
+625
+60% +$4.86K ﹤0.01% 2691
2025
Q2 		$6.51K Sell
1,034
-813
-44% -$5.38K ﹤0.01% 3017
2025
Q1 		$11.8K Buy
1,847
+1,348
+270% +$11.1K ﹤0.01% 2669
2024
Q4 		$4.01K Buy
499
+259
+108% +$2.5K ﹤0.01% 3002
2024
Q3 		$3.03K Buy
240
+194
+422% +$2.5K ﹤0.01% 2930
2024
Q2 		$582 Sell
46
-54
-54% -$543 ﹤0.01% 3181
2024
Q1 		$478 Buy
+100
New +$464 ﹤0.01% 3112

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

GAMMA Investing's NVAX Position: Q2 2026 in Review

GAMMA Investing reduced its Novavax (NVAX) stake by 14% in Q2 2026, selling an estimated $1.43K and leaving 952 shares worth $8.97K. The position accounts for ﹤0.01% of the portfolio, ranked #3266.

GAMMA Investing first reported a position in NVAX in Q1 2024 and has held it in 10 quarters since. The position peaked at $14.4K in Q3 2025. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • GAMMA Investing held 952 shares of Novavax worth $8.97K as of Q2 2026.
  • GAMMA Investing sold 160 Novavax shares in Q2 2026, an estimated $1.43K.
  • Novavax made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3266 holding.
  • GAMMA Investing first reported a position in Novavax in Q1 2024 and has held it in 10 quarters since.
  • GAMMA Investing's Novavax position peaked at $14.4K in Q3 2025.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.